Nanotechnology Now - Press Release: Solegear Further Strengthens its Product Development Team: New Hire Seeks to Create New, Disruptive, Sustainable Materials

Home > Press > Solegear Further Strengthens its Product Development Team: New Hire Seeks to Create New, Disruptive, Sustainable Materials

Abstract:
Solegear Bioplastic Technologies Inc. (TSX VENTURE:SGB) is pleased to announce the addition of Dr. Sadaf Shafiei Sabet to its biopolymer engineering team.

Solegear Further Strengthens its Product Development Team: New Hire Seeks to Create New, Disruptive, Sustainable Materials

Vancouver, Canada | Posted on June 17th, 2015

Dr. Sabaf Shafiei Sabet holds a PhD in Chemical and Biological Engineering from the University of British Columbia and also holds a BSc. and MSc. in Polymer Engineering and Nanotechnology, and has completed extensive practical research using nanotechnology to improve the performance of bioplastics. "We are extremely proud to have Dr. Shafiei Sabet join our talented product development team, " stated Dr. Michel Labonté, Solegear's Chief Technology Officer. "At the University of British Columbia, Dr. Shafiei Sabet gained in-depth knowledge of biomaterials and expertise in the rheology of complex systems to manage the unique flow characteristics of biopolymers. Dr. Shafiei Sabet is driven to apply her knowledge and expertise towards development of sustainable engineering materials, and we expect she will prove to be a tremendous addition to our team."

Dr. Labonté has led Solegear's biopolymer engineering team since 2010, creating Solegear's portfolio of proprietary, patent-pending Polysole® and Traverse® biopolymer product lines. Having previously worked in technical capacities within Canadian companies such as Bombardier and Cascades, Dr. Labonté has also designed and led university-level plastics curriculums both nationally and internationally. Michel holds a Bachelor of Business Administration from École des Hautes Études Commerciales (HEC) of Montreal, Canada and a Ph.D from École Polytechnique de Montréal, one of Canada's leading plastics technology institutions.

"Hiring Dr. Sabet Shafiei is an example of Solegear's continuous efforts to identify the very best talent emerging from material science universities in Canada," stated Dr. Labonte. "We continue to see a growing interest and passion amongst young engineers at our universities who want to direct that passion toward creating new disruptive, sustainable materials. This source of talent and fresh creativity is an important asset in Solegear's continued growth as a leading innovator in the bioplastics industry."

####

About Solegear Bioplastic Technologies Inc.
Solegear, based in Vancouver, British Columbia, is an innovator in the field of next-generation plastics. The Company is an advanced materials firm that engineers, produces and distributes high-performance bioplastics (bioplastics are a category of plastics that are bio-based, compostable, or both) through a capital efficient business model. Founded in 2006, Solegear has developed, and is commercializing, proprietary bioplastics technologies that utilize annually renewable plant-based ingredients formulated using green chemistry, to address the growing North American market opportunity for rigid consumer packaging and durable plastic goods. www.solegear.ca

On behalf of the Company:

Paul Antoniadis, Chief Executive Officer and Director

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibilities for the adequacy or accuracy of this release.

Cautionary Statement Regarding Forward-Looking Information

Information in this news release that is not current or historical factual information may constitute forward-looking information within the meaning of securities laws. Implicit in this information, particularly in respect of the expected benefits of hiring Dr. Sabat to our product development team, are assumptions regarding Dr. Sabat's ability to contribute to Solegear's product development efforts. These assumptions, although considered reasonable by the Company at the time of preparation, may prove to be incorrect. Readers are cautioned that actual results are subject to a number of risks and uncertainties, inherent in any new hire and expected performance could differ materially from what is currently expected as set out above.

Other than as required under securities laws, we do not undertake to update this information at any particular time.

To the extent the Company is providing forward-oriented financial information or a financial outlook in this news release, such information/outlook is provided to demonstrate the potential of the Company and readers are cautioned that this information may not be appropriate for any other purpose.

Forward-looking information contained in this news release is based on our current estimates, expectations and projections, which we believe are reasonable as of the current date. The reader should not place undue importance on forward-looking information and should not rely upon this information as of any other date. All forward-looking information contained in this news release is expressly qualified in its entirety by this cautionary statement.

For more information, please click here

Contacts:
Company Contact:
Solegear Bioplastic Technologies Inc.
Paul Antoniadis
CEO and Director
+1-604-998-4058

Investor & Media Contact:
Fred Leigh
Kin Communications
1-866-684-6736

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: